There are 34 papers on IGFBP5 in aging research: 3 trials and 7 observational studies in people, 8 in animals, 9 in cells, 4 reviews.
1 new paper in 30 daysSee all 34 papers on IGFBP5
At a glance
The findings reach people, from one lab or study; independent labs found the same change in cells. 11 independent labs in 7 countries.
“Higher abundance of AK4, HSPB2, and IGFBP5 was associated with faster cognitive decline and mediated through lower postmortem R2 in the frontal and temporal white matter regions”
2 of its findings point the other way.
- 11 independent labs in 7 countries
- 2 findings against
- Funders: National Natural Science Foundation of China and others
- Human trial3
- Humans7
- Animals8
- Cells9
- In silico3
Interventions
1Mechanical stress
upin human cells1
1 study
Mechanical stress
upin human cells1
Mechanical stress increases IGFBP5 in human cells (human aged osteochondral explants) (FC = 6.01; FDR = 7.81 × 10−3).
“IGFBP5 (FC = 6.01; FDR = 7.81 × 10−3) and MMP13 (FC = 5.19; FDR = 4.84 × 10−2) were the highest upregulated genes”
Cellshuman aged osteochondral explantsstrain of 65%articular cartilage
Arthritis research & therapy
Effects
4Cellular senescence
upin cells2downin human cells1upin human cells1is required forin human cells1+4
9 studies
Cellular senescence
upin cells2downin human cells1upin human cells1is required forin human cells1+4
IGFBP5 inhibits cellular senescence in DFSCs undergoing replicative or H2O2-induced senescence.
“IGFBP5 overexpression alleviated cellular senescence and enhanced osteogenic potential”
Cellsin DFSCs undergoing replicative or H2O2-induced senescence
International journal of oral science
IGFBP5 increases cellular senescence.
“IGF-binding protein-5 (IGFBP-5), which amplifies senescence in vascular and stromal cells”
Reviewvascular and stromal cells
The IGF-1 senescence switch: a biphasic model for SASP-driven aging and precision senomodulation
Cytokine
IGFBP5 induces cellular senescence in cells.
“IGFBP5 actively contributes to promoting senescence and can induce senescence in neighboring cells.”
Cells
Cell communication and signaling : CCS
IGFBP5 induces cellular senescence in AGS cells.
“increase aging biomarkers (SA-β-galactosidase, p53, and p21)”
Cellsin AGS cells
Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis
Critical reviews in immunology
IGFBP5 increases cellular senescence in cells (shown by overexpression and knockdown in PDLSCs).
“IGFBP5 can accelerate the senescence of PDLSCs”
Cellsshown by overexpression and knockdown in PDLSCs
Cell and tissue banking
IGFBP5 decreases cellular senescence in P2 MEFs.
“Downregulation of IGFBP5 via siRNA in P2 MEFs increased the number of SA-β-GAL-positive cells, upregulated p16 and p19, and inhibited cell growth.”
Cellsin P2 MEFsembryonic fibroblasts
Aging
IGFBP5 is required for cellular senescence in human cells (IGFBP-5 knockdown in Y-27632-treated human dermal fibroblasts).
“knockdown of IGFBP-5 blocked the Y-27632-induced senescence”
CellsIGFBP-5 knockdown in Y-27632-treated human dermal fibroblasts
Aging
IGFBP5 mediates cellular senescence in human cells (shown by knockdown of FXa-induced senescence).
“Inhibition of FXa signaling with rivaroxaban or knock down of IGFBP-5 significantly reduced FXa-induced VSMC senescence and inflammatory cytokine production”
Cellsshown by knockdown of FXa-induced senescencevascular smooth muscle cell
Scientific reports
IGFBP5 mediates cellular senescence in humans (downstream of STAT3 in human fibroblasts).
“STAT3-insulin-like growth factor-binding protein 5 (IGFBP5) as a key axis triggering and reinforcing component in human fibroblasts”
Reviewdownstream of STAT3 in human fibroblasts
IL-6-STAT3 signaling and premature senescence
JAK-STAT
Osteogenic differentiation
upin human cells1
1 study
Osteogenic differentiation
upin human cells1
IGFBP5 improves osteogenic differentiation in DFSCs undergoing replicative or H2O2-induced senescence.
“IGFBP5 overexpression alleviated cellular senescence and enhanced osteogenic potential”
Cellsin DFSCs undergoing replicative or H2O2-induced senescence
International journal of oral science
Thymocyte proliferation
downin human cells1
1 study
Thymocyte proliferation
downin human cells1
IGFBP5 inhibits thymocyte proliferation in human cells (shown by knockdown).
“knockdown of IGFBP5 significantly increased the expression of proliferation-related genes in thymocytes”
Cellsshown by knockdownthymocytes
Frontiers in immunology
Viability
downin human cells1
1 study
Viability
downin human cells1
IGFBP5 decreases viability in AGS cells.
“IGFBP5 overexpression in AGS cells was found to decrease viability, migration, and invasion”
Cellsin AGS cells
Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis
Critical reviews in immunology
Upstream
1Pelvic organ prolapse
downin humans1
1 study
Pelvic organ prolapse
downin humans1
Pelvic organ prolapse is linked with lower IGFBP5 in POP patients vs controls.
“The expression levels of protein and mRNA of IGFBP5, collagen I, and collagen III were significantly lower in the POP group.”
Humansin POP patients vs controlsanterior vaginal wall
Scientific reports
Associations
5Cellular senescence
upin mouse cells1upin reviews1
2 studies
Cellular senescence
upin mouse cells1upin reviews1
IGFBP5 is associated with cellular senescence.
“IGF binding protein-5 (IGFBP-5) with the induction of the tumor suppressor p53 is upregulated during cellular senescence.”
Review
IGF Binding Protein-5 Induces Cell Senescence
Frontiers in endocrinology
IGFBP5 is associated with cellular senescence in mouse cells (age-related upregulation).
“concomitant upregulation of miR-143 target gene, Igfbp5, is associated with increased cell senescence, thus affecting myogenesis.”
Cellsage-related upregulationsatellite cells
Age-related changes in miR-143-3p:Igfbp5 interactions affect muscle regeneration
Aging cell
Pelvic organ prolapse
downin humans1
1 study
Pelvic organ prolapse
downin humans1
Pelvic organ prolapse is associated with IGFBP5 in POP patients.
“IGFBP5 protein and mRNA expression levels were also significantly lower in POP-Q stage IV patients compared to POP-Q stage III patients.”
Humansin POP patientsanterior vaginal wall
Scientific reports
Age
downin humans1
1 study
Age
downin humans1
age is associated with IGFBP5 in POP patients.
“IGFBP5 protein and mRNA expression levels were negatively correlated with age and significantly lower in older POP patients (≥ 65 years old) compared to younger POP patients (< 65 years old).”
Humansin POP patientsanterior vaginal wall
Scientific reports
Mortality
upin silico1
1 study
Mortality
upin silico1
IGFBP5 predicts mortality in silico (prognosis model in GC) (AUC > 0.669).
“The AUC values of the model were greater than 0.669, exhibiting strong prognostic value.”
In silicoprognosis model in GC
Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis
Critical reviews in immunology
Cognitive decline
upin humans1
1 study
Cognitive decline
upin humans1
IGFBP5 is associated with cognitive decline in humans (mediated through lower postmortem R2 in frontal and temporal white matter).
“Higher abundance of AK4, HSPB2, and IGFBP5 was associated with faster cognitive decline and mediated through lower postmortem R2 in the frontal and temporal white matter regions”
Humansmediated through lower postmortem R2 in frontal and temporal white matterbrainn = 521
Neurobiology of aging
Funding
1 grant since 2026American Heart Association$231K